| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |